The Swiss Biotech Directory

4bases is a company active in the fields of prevention and precision medicine. 4bases is a certified company working accordingly to the IVDR regulation. Our products are reagent kits for platform-independent New Generation DNA Sequencing (NGS), data analysis software and diagnostic protocols.

4G Clinical is a global leader in randomisation and trial supply management and supply forecasting optimisation software for the life sciences industry, offering a fully cloud-based, 100% configurable solution using natural language processing to accelerate clinical trials.

7AlpsBio Consulting Services offers expertise in healthcare in strategic, operational, project support and a management know-how with a focus on ATMPs, biopharmaceuticals and life sciences in (pre)clinical development, GMP manufacturing from clinical trials to commercialization.

Abbmira Therapeutics is a Basel-based biotech founded by experienced scientists and entrepreneurs in September 2024. Abbmira develops first-in-class small molecules to fine-tune native immunity to treat difficult-to-treat cancers and chronic diseases.

abc biopply AG is pioneering NAM technologies and organoid CRO services that boost in vitro studies for drug discovery and development to IND relevance using its proprietary 3D CoSeedis Multi-Organoid in chip Technology™ on clinically relevant disease models (oncology, neurology, obesity and others).

Provides services in business development, strategy and product evaluation.

AC Immune SA is a clinical-stage biopharma that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and NeuroOrphan indications. The company has two clinically validated technology platforms, SupraAntigen® and Morphomer®.

ACBio delivers marketing & communications strategies, content, and brand narratives to life science companies worldwide to help them gain market leadership. We blend PhD-level scientific knowledge with effective marketing tactics to translate complex tech into understandable value for stakeholders.

Accelsiors is a global, full-service clinical research organization delivering end-to-end trial solutions under one roof. For over 20 years, we’ve supported biopharma with scientific, regulatory, legal, and operational expertise, driving efficient, high-quality clinical development worldwide.

ACM Biosciences AG is a subsidiary of ACM Biolabs PTE Ltd. Singapore. Its purpose is to internationalise its development activities. It leads all clinical and regulatory activities of its pipeline programs and coordinates business development discussions with potential partners.

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.

Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.

ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs.

Adiposs is a medtech start-up company, a spin-off of the University of Geneva, developing medical imaging products and technologies.

ADM is a global leader in both human and animal nutrition. With industry-advancing innovations, a complete portfolio of ingredients and solutions to meet any taste, and a commitment to sustainability, we give customers an edge in solving the nutritional challenges of today and tomorrow.

Kuhner AG is a leading developer and manufacturer of shaking machines, single use bioreactors, automation systems and online measuring technology for the international market. Furthermore, Kuhner sales lab-equipment (freeze dryers, centrifuges, etc.) to the Swiss market.

Adoram is a UNIGE spinoff that is developing next-generation allosteric small molecule drugs targeting A2A receptors for cancer and inflammatory diseases, powered by a proprietary AI-enhanced GPCR discovery platform and in-house screening technologies for rapid, high-quality lead generation.

We identified a novel immuno-oncology target through bacterial metabolites that activate tumor-residing macrophages, triggering a potent anti-tumor response. By leveraging natural metabolic processes, we develop small molecule therapies to enhance the body’s native immune defense against cancer.

Advanced Clinical is a privately held clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal is to improve the lives of those touched by clinical research and help our clients get better outcomes.

Zürich-based health technology company building clinical AI for European primary care. The Jupiter Ecosystem connects an EHR, a patient app and Dia, an AI clinical reasoning layer: AI proposes, the physician decides. ahtida’s live digital clinic is the proprietary data engine.

Akceso Advisors: specialist advisory firm focused on pricing, reimbursement and market access. For your buy/sell side 'Evidence-based Asset Valuation' and payer-relevant input into your development plan design. Akceso Advisors: Catalysts to patient access and pricing success. For better public health worldwid

Alentis Therapeutics is a clinical-stage biotechnology company developing first-in-class therapies targeting claudin-1 for a range of fibrosis and oncology indications. We are rapidly advancing our pipeline of antibodies and antibody-drug conjugates through clinical development.

We develop animal-based products via cell cultivation, combining proprietary animal cell biology with scalable bioprocessing at favorable unit economics. The platform starts with the world's first cultivated whole-cut beef and expands into functional applications, like cell-derived collagen.

At Alithea Genomics we develop, produce and commercialize cutting-edge solutions for drug and biomarker discovery based on gene expression. Our products provide high throughput and cost-efficiency, which is ideal for large-scale projects such as drug screening and biomarker discovery.

Allegria Therapeutics was founded in Basel in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.

Alloy Therapeutics is a biotechnology ecosystem company democratizing access to tools, technologies, and services for discovering and developing therapeutic biologics across six modalities, including antibodies, TCRs, genetic medicines, peptides, cell therapy, and drug delivery.

Almac provides the most comprehensive global clinical supply chain solution in the marketplace. Guided by our extensive supply experience, we provide the physical resources and supportive technologies that ensure your clinical supply chain continually delivers across the globe.

Alp Bio AG is a Swiss biotech startup that combines human immune organoid technology with generative AI. The company provides immunogenicity intelligence to detect and mitigate anti-drug antibody (ADA) risks years before clinical trials, helping developers avoid costly late-stage failures.

Alpha Lyncis SA is a Swiss-based service provider supporting implementation and transfer of biotechnological and chemical production processes. We complement our customers teams to develop holistic solutions for manufacturing challenges and accelerate the success of highly regulated products.

AlphaMol is an AI-based bio-pharmaceutical company focusing on G protein-coupled receptor drug discovery. The co-founders of AlphaMol are leading scientists in the area of GPCRs. Many essential molecular mechanisms and biotechnology were invented by the members of AlphaMol.

Alpinuity Bio aims to provide consulting services in the field of biopharmaceutical R&D specifically in translational science and biomarkers. We advise and support investors, start-ups and established companies in due diligence, scientific and technical aspects.

Altasciences is a forward-thinking CRO offering a flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing and analytical services. Altasciences’ solutions include preclinical safety testing, clinical pharmacology and POC, bioanalysis, and CRO services.

Altorfer Engineering is a specialized contractor and consulting company. We provide expertise in engineering and project management services, and technology transfers. Our focus is on developing and managing aseptic formulation and fill-finish processes tailored to your receiving sites.

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.

Swiss health science co. pioneering clinically proven products to promote cellular health and longevity. The company’s proprietary nutrient, Mitopure, is clinically shown to combat age-related declines in mitochondrial health and muscle function. Nestlé Health Science is a global strategic partner.

Amphasys is a leading provider of label-free cell analysis solutions for cells from 1 to 250 um. Characteristics such as size, count and morphology, viability, metabolic and health status are determined real-time. Amphasys is market leader in pollen analysis in the seed industry.

Amphilix AG is a Basel-based biotech developing next-generation radioligand therapies using a proprietary 3D linker platform and small-molecule ligands. Its clinical-stage lead AMX-0053 targets a protein for colorectal cancer and is ready for First-in-Human imaging. The company seeks CHF 9m Seed.

Amporin is developing a new class of small molecule amyloid pore inhibitors as the first potential acute oral drugs to stop and reverse the progression of deadly degenerative diseases. Our vision is to cure 6 major degenerative diseases with a simple pill, starting with Parkinson’s disease.

AMYRA is developing a unique enzyme combination for curative care of Celiac Disease and Non-Celiac Gluten Sensitivity (NCGS), which represent major public health issues. AMYRA’s products have the potential to establish the standard of care and majorly impact the lives of affected people.

Anaveon is a global clinical stage biopharmaceutical company that specializes in developing novel treatments for diseases with high unmet needs. Our team is driven to make this vision a reality: we are committed to transforming immunological insights into life-changing therapies.

AND Biotech is a science-led company developing bioactive technologies that target the core systems of human resilience. We take promising compounds and translate them into clinically meaningful interventions. We develop scalable technologies that address biological decline, starting long before disease.

ANSEA is a global consulting firm enabling pharmaceuticals, biopharmaceuticals and medical device companies navigate through the complexities of healthcare systems across the world and helping bring their solutions to patients.

We focus our efforts on supporting injection devices, medical devices, IVD, combination product developments and compliance projects for our pharmaceutical and biotech clients, who either lack resources familiar with medical device development or wish to complement their existing resources.

Antion’s mirGE™ platform enables precise multiplex gene silencing with synthetic miRNAs, allowing independent modulation of up to 7 targets in a single step. Compatible with viral and non-viral delivery, it is designed for scalable, safe and effective ex vivo and in vivo therapies and R&D models.

APR Applied Pharma Research s.a. (wholly owned by Relief Therapeutics Holding AG, SIX: RLF.SW), is a B2B Swiss-based international biopharma focused on development and global commercialization of innovative, patent protected products designed to address unmet needs.

Apricot BIO is a first-time launcher of a Functional Precision Oncology platform performing deep molecular phenotyping of drug responses for personalised therapy recommendations for early to late-stage clinical decision-making leading to more precise, evidenced-based recommendations for doctors.

Aptissen is specialized in the development, distribution, and marketing of viscosupplements/orthobiologic solutions and drinkable food supplement in the area of joint health and soft tissue.

arcoris bio develops next-generation technologies for biomarker detection in research and diagnostics. Its flagship MUSE platform provides universal, programmable signal amplification to enable highly sensitive and multiplex assays that drive the future of digital pathology.

ARTBIO is a clinical-stage radiopharmaceutical company focused on developing a new class of alpha radioligand therapies (ARTs) to transform cancer treatment. ARTBIO's approach centers on utilizing the alpha-emitting isotope Pb212 to target cancer cells while minimizing damage to healthy tissues.

Artidis® is a pioneering clinical stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. Artidis focuses its efforts on solid tumors to enhance responses to chemo, immuno, and cell therapies, driving precision in cancer care.

Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need, including orphan tauopathies, Alzheimer’s and Parkinson’s disease.

Asemblis is a Swiss biotech company developing scalable, human-relevant in vitro models for obesity and metabolic disorders. The company partners with industry and research organizations to support translational R&D and decision-making in drug development.

Aspeya, owned by Philip Morris International, operates independently and utilizes Fertin Pharma's oral technology platform. Fertin Pharma, a wholly owned subsidiary of Aspeya, is a CDMO that develops and manufactures innovative oral and intra-oral delivery systems.

At ATANIS Biotech AG, our mission is to revolutionize the way allergies are diagnosed and thereby to improve treatment success Our novel cell-based assay allows us to quantify patients allergic status with unparalleled diagnostic accuracy, without needing to expose patients to the culprit allergen.

Athebio develops ultra-stable biotherapeutics using proprietary Athebody® DARPin molecules with high affinity and specificity. We partner on radiotherapeutics, T cell engagers, targeted delivery (LNP/AAV/oligo) and affinity ligands, enabling breakthrough therapeutic strategies.

Atopia Therapeutics is developing a revolutionary treatment for allergic diseases such as atopic dermatitis, allergic asthma, food allergies and hay fever based on the discovery that a bacterium present in the human stomach produces a protein that protects us from these diseases.

Aukera Therapeutics is a preclinical stage company developing the first RAPTOR inhibitors, a new approach to selectively modulate the proven target mTORC1. The lead program focuses on genetically-driven epilepsies such as TSC. Future use include age-related and neurodegenerative diseases.

Aurealis Therapeutics is a Swiss-Finnish cell and gene therapy platform company. Our multi-target scalable low COGS products, based on genetically engineered lactic acid bacteria, addresses unmet medical needs: Chronic wounds - diabetic foot ulcers, venous ulcers, pressure ulcers - deadly cancers - ovarian ca

AVEctivate supports pharma, biotech and diagnostic companies aiming to make a positive difference to patients, and health care providers by offering strategic consulting, project management and interim management. Believing that change is the only constant, we embrace the future as an opportunity.

Avenza Consulting has been created to support pharma, biotech companies, startups to develop and grow by offering Strategic Consulting, R&D services to foster innovation, Program & Portfolio Management to optimize projects, and Operational Excellence to streamline processes.

Spin-off from EPFL developing precision gene therapies for Amyotrophic Lateral Sclerosis (ALS). ALS pathogenic mechanisms support that non-neuronal cells play a key role in this disease, through reshaping neuronal synaptic connections.

AxCellerate is a Swiss BioTech company offering pre-clinical research services through its organ-on-chip technologies, using proprietary systems and human-derived cells to to mimic the complexity of the central and peripheral nervous system.

Axcura AG is a Swiss life-science partner supporting regulated pharmaceutical and biopharmaceutical supply chains. We combine qualified sourcing of APIs, excipients, intermediates and biopharma ingredients with ISO 9001 quality management, PIC/S GDP distribution and audit-ready documentation.

Axxam S.p.A. is a CRO delivering integrated early drug discovery, from target identification to lead generation. Through its DiscoveryMAXX platform, it supports pharma, biotech, start-ups, and academia with biology-driven solutions across all therapeutic areas and target classes.

Azafaros is a clinical-stage biotech company addressing rare genetic lysosomal storage disorders with oral small molecules, including nizubaglustat. Our focus is on developing disease-modifying therapies for patients with, among others, GM1 and GM2 gangliosidoses, and Niemann-Pick Type C disease.

AzureCell is a Swiss regenerative cell therapy company leveraging two decades of pioneering neuroscience and cell‑engineering research at the University of Geneva to advance next‑generation allogeneic cell‑replacement therapies for the brain.

B Squared helps biotech and cell & gene therapy companies navigate complex CMC, manufacturing, and sourcing challenges. We bring hands-on expertise, real-world solutions, and a no-nonsense approach to getting things done.

Baccinex is a CDMO specialized in the manufacturing of sterile (liquid & lyophilized) Drug Product. Our service includes: scale-up from laboratory to GMP, GMP manufacturing, clinical packaging, QC release analytics, stability studies programs, GMP storage. Baccinex was acquired by Adragos Pharma in 2024.

Baker McKenzie is an international law firm with offices in Geneva and Zurich, offering top-tier legal advice across all areas of business law. Our team of 130 lawyers provides domestic and international clients with innovative solutions across 74 offices in 45 countries.

Baliopharm AG, is a biotechnology company focusing on the development of innovative therapeutics for the treatment of chronic liver diseases, immune mediated inflammatory diseases, as well as for cancer.

Basel Biotech Consutling GmbH provides biotechs and mid-stage pharmas with support on financing and business development. The expertise is based on over 20 years experience in investments having worked as a pharma analyst, fund manager, investor relations and business development professional.

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN) is a commercial-stage biopharmaceutical company headquartered in Switzerland. Basilea is committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections.

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.

At BD, we are committed to sustainable healthcare. We are inspired by childhood to be innovative thinkers, to be ambitious in our ways of caring about the patients and healthcare professionals of tomorrow.

Beech Biotech is developing a novel treatment for preeclampsia, an severe unmet medical need that takes the lives of 70,000 women and 500,000 babies each year. The company is developing a novel placenta-impermeable antibody and works with a network of expert industry consultants and contractors.